These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7032945)
1. The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer. Stewart HJ; Forrest AP; Gunn JM; Hamilton T; Langlands AO; McFadyen IJ; Roberts MM Eur J Cancer (1965); 1980; Suppl 1():83-8. PubMed ID: 7032945 [No Abstract] [Full Text] [Related]
2. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer. McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323 [No Abstract] [Full Text] [Related]
3. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women. Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918 [No Abstract] [Full Text] [Related]
4. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial. Mouridsen HT; Palshof T; Engelsman E; Sylvester R Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921 [No Abstract] [Full Text] [Related]
5. Adjuvant endocrine therapy of primary operable breast cancer. Report on the Copenhagen breast cancer trials. Palshof T; Mouridsen HT; Daehnfeldt JL Eur J Cancer (1965); 1980; Suppl 1():183-7. PubMed ID: 7032931 [No Abstract] [Full Text] [Related]
6. Tamoxifen and fluoxymesterone in advanced breast cancer: a controlled clinical trial. Westerberg H Cancer Treat Rep; 1980 Jan; 64(1):117-21. PubMed ID: 6991101 [TBL] [Abstract][Full Text] [Related]
7. Preliminary report of a controlled trial in advanced breast cancer comparing tamoxifen with conventional hormone therapy. Roberts HM; Forrest AP; Hamilton T; Langlands AO; Lutz W; McFadyen IJ; Stewart HJ Cancer Treat Rep; 1976 Oct; 60(10):1461-2. PubMed ID: 798627 [No Abstract] [Full Text] [Related]
8. DES versus tamoxifen in advanced breast cancer. N Engl J Med; 1981 Apr; 304(17):1041-3. PubMed ID: 7010171 [No Abstract] [Full Text] [Related]
9. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer. Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526 [TBL] [Abstract][Full Text] [Related]
10. [Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity]. Murayama Y Gan No Rinsho; 1984 Dec; 30(15):1879-82. PubMed ID: 6543230 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer. Mouridsen H; Chaudri-Ross HA Oncologist; 2004; 9(5):497-506. PubMed ID: 15477634 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial. Smith IE; Dowsett M; Ebbs SR; Dixon JM; Skene A; Blohmer JU; Ashley SE; Francis S; Boeddinghaus I; Walsh G; J Clin Oncol; 2005 Aug; 23(22):5108-16. PubMed ID: 15998903 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52. Ingle JN; Suman VJ; Mailliard JA; Kugler JW; Krook JE; Michalak JC; Pisansky TM; Wold LE; Donohue JH; Goetz MP; Perez EA Breast Cancer Res Treat; 2006 Jul; 98(2):217-22. PubMed ID: 16538529 [TBL] [Abstract][Full Text] [Related]
14. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data. Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881 [TBL] [Abstract][Full Text] [Related]
15. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. Cohen MH; Johnson JR; Li N; Chen G; Pazdur R Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893 [TBL] [Abstract][Full Text] [Related]
16. Antiestrogen treatment of breast cancer: an overview. Pearson OH; Manni A; Arafah BM Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524 [TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. Ingle JN; Ahmann DL; Green SJ; Edmonson JH; Bisel HF; Kvols LK; Nichols WC; Creagan ET; Hahn RG; Rubin J; Frytak S N Engl J Med; 1981 Jan; 304(1):16-21. PubMed ID: 7001242 [TBL] [Abstract][Full Text] [Related]
18. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether in the treatment of advanced breast cancer: Japanese Cooperative Group of Hormonal Treatment for Breast Cancer. Cancer; 1978 Feb; 41(2):758-60. PubMed ID: 343913 [TBL] [Abstract][Full Text] [Related]
19. Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional ability. Mouridsen H; Sun Y; Gershanovich M; Perez-Carrion R; Becquart D; Chaudri-Ross HA; Lang R Oncologist; 2004; 9(5):489-96. PubMed ID: 15477633 [TBL] [Abstract][Full Text] [Related]
20. Tamoxifen and breast cancer--from palliation to prevention. Rich SE Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]